guvacoline has been researched along with n-(4,4-diphenyl-3-butenyl)nipecotic acid in 1 studies
Studies (guvacoline) | Trials (guvacoline) | Recent Studies (post-2010) (guvacoline) | Studies (n-(4,4-diphenyl-3-butenyl)nipecotic acid) | Trials (n-(4,4-diphenyl-3-butenyl)nipecotic acid) | Recent Studies (post-2010) (n-(4,4-diphenyl-3-butenyl)nipecotic acid) |
---|---|---|---|---|---|
11 | 0 | 7 | 121 | 0 | 22 |
Protein | Taxonomy | guvacoline (IC50) | n-(4,4-diphenyl-3-butenyl)nipecotic acid (IC50) |
---|---|---|---|
Cytochrome P450 3A4 | Homo sapiens (human) | 0.6918 | |
Sodium- and chloride-dependent GABA transporter 1 | Homo sapiens (human) | 0.165 | |
Sodium- and chloride-dependent GABA transporter 1 | Mus musculus (house mouse) | 0.4099 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ali, FE; Bondinell, WE; Dandridge, PA; Frazee, JS; Garvey, E; Girard, GR; Kaiser, C; Ku, TW; Lafferty, JJ; Moonsammy, GI | 1 |
1 other study(ies) available for guvacoline and n-(4,4-diphenyl-3-butenyl)nipecotic acid
Article | Year |
---|---|
Orally active and potent inhibitors of gamma-aminobutyric acid uptake.
Topics: 4-Aminobutyrate Transaminase; Administration, Oral; Alkylation; Amino Acids; Animals; Brain; Carboxylic Acids; gamma-Aminobutyric Acid; Glutamate Decarboxylase; In Vitro Techniques; Male; Neurotransmitter Uptake Inhibitors; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, GABA-A; Receptors, Neurotransmitter; Stereoisomerism; Synaptosomes | 1985 |